Jump to navigation
Harris D, Casso D, Midkiff K, Anderson A, Gilsenan A, Oliveria A, Andrews E, Kellier-Steele N. Methods, results, and lessons learned from two postmarketing drug safety surveillance studies linking state cancer registry data to large pharmacy databases. Presented at the 2019 NAACCR / IACR Combined Annual Conference; June 11, 2019. Vancouver, Canada.
Dunne JL, Sutphin J, Bushman JS, Fontanals-Cirera B, Coulter JR, Hutton CT, Koralova A, Ervin CM, Mansfield C. Parent and physician preferences for screening in Type 1 diabetes (T1D). Poster presented at the American Diabetes Association’s 79th Scientific Sessions; June 10, 2019. San Francisco, CA.
Donnelly A, Christopher S, Chaudhuri S, Hauber AB, Mange B, Benz HL, Caldwell B, Gwinn K, Saha A, Ho M, Sheehan M, McLaughlin L, Sheldon M, Lo A. Expedited access to therapies: how measuring and incorporating patient preferences can make clinical trials more efficient and more effective. Poster presented at the 5th World Parkinson Congress; June 5, 2019. Kyoto, Japan.
Kummar S, Mascarenhas L, Geoerger B, Turpin B, Cox, MC, Yu S, Nanda S, Hiemeyer F, Keating KN, Chirila C, Gnanasakthy A, Davenport E, Hong DS, Drilon AE. Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib. Poster presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting; June 1, 2019. Chicago, IL. [abstract] J Clin Oncol. 2019 Jun; 37(2019):6602.
Fizazi K, Shore ND, Tammela T, Kuss I, Le Berre M, Mohamed AF, Odom D, Bartsch J, Snapir A, Sarapohja T, Smith MR. Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (Pts) with nonmetastatic castrate-resistant prostate cancer (nmCRPC). Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting; May 31, 2019. Chicago, IL. [abstract] J Clin Oncol. 2019 Jun; 37(2019).
Rebordosa C, Aguado J, Plana E, Thomas S, Frances A, Lei A, Garcia-Gil E, Nuevo J, Perez-Gutthann S, Castellsague J. Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom. Respir Med. 2019 Jun;152:37-43.
Gemzoe K, Crawford R, Caress A, Rushton R, Shah A, Collier S, Doward L, Vekaria R, Worsley S, Leather DA. Patient and healthcare professional (HCP; general practitioner [GP] and practice manager [PM]) insights to facilitate engagement in future effectiveness studies: learnings from the Salford Lung Studies (SLS). Poster presented at the 2019 American Thoracic Society (ATS) International Conference; May 22, 2019. Dallas, TX.
Zuluaga Sanchez S, Purser M, Mader G, Gould IG, Knight C, Johnson NB, Patel M, Jensen J, Odom T. Improved quality of life and life-years in patients with infantile-onset SMA following treatment with nusinersen. Poster presented at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Zuluaga Sanchez S, Purser M, Mader G, Gould IG, Knight C, Patel M, Odom T, Jensen J, Johnson NB. Improved quality of life for patients and caregivers among patients with later-onset SMA following treatment with Nusinersen. Poster presented at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Carrico J, Jia X, Zhao Y, Zhang J, Brodtkorb TH, Mendelsohn AB, Lowry S, Wu JJ, Feldman SR, Armstrong AW. Budget-impact and cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis from a US health plan perspective. Poster presented at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
Gabriel A, Apostolides J, Nickodem A, Rad AN, Patel V, Zaw R, Martin S, Harris N, Jones G, Nahabedian MY. Patient experience with different implant breast reconstruction surgeries. Poster presented at the ISPOR 24th Annual International Meeting; May 20, 2019. New Orleans, LA.